Completed OBSERVATIONAL NCT06318117

Reason for Prescribing Rice Infant Formula

Observational Study on the Use of Infant Formulas Based on Rice Protein Hydrolysate in Real Life Conditions

Sponsor: BioFortis

Updated 6 times since 2024 Last updated: Jan 28, 2026 Started: Mar 12, 2024 Primary completion: Oct 31, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Infant Formula and is currently completed. BioFortis leads this study, which shows 6 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Completed

Status: Recruiting → Completed
Sep 2025 — Feb 2026 [monthly]

Recruiting
Apr 2025 — Sep 2025 [monthly]

Recruiting
Sep 2024 — Apr 2025 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting

▶ Show 1 earlier version

Apr 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Mar 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BioFortis
Mead Johnson Nutrition

Data source: Mead Johnson Nutrition

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Attiches, France , Auxerre, France , Boulogne-Billancourt, France , Brest, France , Brignon, France , Bécon-les-Granits, France , Foix, France , Hyères, France , Le Havre, France , Libourne, France and 6 more locations